Đang chuẩn bị liên kết để tải về tài liệu:
Disease pathway cut for multi-target drugs

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Biomarker discovery studies have been moving the focus from a single target gene to a set of target genes. However, the number of target genes in a drug should be minimum to avoid drug side-effect or toxicity. But still, the set of target genes should effectively block all possible paths of disease progression. |

TÀI LIỆU LIÊN QUAN

Disease pathway cut for multi-target drugs

A novel pathway-based distance score enhances assessment of disease heterogeneity in gene expression

Pathway activity inference for multiclass disease classification through a mathematical programming optimisation framework

Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease

Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels

Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation

A long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway

Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis

Báo cáo khoa học: Emerging pathways in genetic Parkinson’s disease: Autosomal-recessive genes in Parkinson’s disease – a common pathway?

Activation of the CXCL16/CXCR6 pathway by inflammation contributes to atherosclerosis in patients with end-stage renal disease
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.